Becton, Dickinson and Company

(New York Stock Exchange)
Slightly Bullish +25

Becton Dickinson stock pre-market at EUR 157.63: plus 0.34 percent

πŸ“ˆ Becton Dickinson stock is trading at EUR 157.63 in pre-market sessions, up 0.34% from the prior close of EUR 157.10.

πŸ‘€ Arthur Hu has been named executive vice president and chief information and digital officer, effective September 30, succeeding retiring executive Denise Russell Fleming.

🏭 Becton Dickinson's Sandy, Utah facility marked 70 years of manufacturing operations while employing more than 1,000 people to produce peripheral intravenous catheters.

πŸ’» The new CIO appointment signals a continued strategic focus on digital transformation and information technology leadership within the medical device sector.

πŸ“… The company released updates regarding its leadership transition and operational milestones in late September 2026.

Bullish Signals
  • Becton Dickinson appointed Arthur Hu as executive vice president and chief information and digital officer, bringing experience from Lenovo to lead the company's digital strategy.
  • The Sandy, Utah facility has successfully operated for 70 years, employing over 1,000 people to produce critical medical components like peripheral intravenous catheters.
Full Analysis
Becton Dickinson and Company (BDX) shares are trading at EUR 157.63 in pre-market sessions on October 5, 2026, representing a modest gain of 0.34% against the previous close of EUR 157.10. The stock is listed on the NYSE with an ISIN of US0758871091 and is currently being quoted by Lang & Schwarz with a bid of EUR 156.05 and an ask of EUR 159.20 ahead of the Xetra open. Significant corporate developments include the appointment of Arthur Hu as executive vice president and chief information and digital officer, effective September 30, 2026. Hu joins BD from Lenovo to succeed retiring executive Denise Russell Fleming, marking a strategic leadership transition in the company's digital operations. Additionally, Becton Dickinson celebrated a major milestone at its Sandy, Utah manufacturing facility, which recently marked its 70th anniversary of production. The site employs over 1,000 people and is responsible for producing peripheral intravenous catheters and molded components, highlighting the company's long-standing operational footprint in medical device manufacturing. The article provides a snapshot of BDX's current market price and highlights key internal appointments and facility anniversaries that underscore the company's ongoing strategic focus on digital transformation and established manufacturing capabilities.